Plasmid-mediated fluoroquinolone resistance determinants in Escherichia coli from community uncomplicated urinary tract infection in an area of high prevalence of quinolone resistance

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 1917-1921

  Longhi, C ^a   Conte, M P ^a   Marazzato, M ^a   Iebba, V ^a   Totino, V ^a   Santangelo, F ^a   Gallinelli, C ^a   Pallecchi, L ^b   Riccobono, E ^b   Schippa, S ^a   Comanducci, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 15; BETA LACTAMASE TEM 1; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; KANAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

AAC(6)' IB CR GENE; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; ESCHERICHIA COLI; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTPATIENT; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; QNRA GENE; QNRB GENE; QNRS GENE; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; GENES, BACTERIAL; HUMANS; ITALY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; POLYMERASE CHAIN REACTION; PREVALENCE; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; YOUNG ADULT;

EID: 84866389760     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1521-6     Document Type: Article

References (14)

1. Gupta K, Hooton TH, Naber KG, BjornW, Colgan R, Miller LG et al (2011) Executive summary: International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 5:103-120
2. Karlowsky JA, Hoban DJ, Decorby MR, Laing NM, Zhanel GG (2006) Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Antimicrob Agents Chemother 50:2251-2254 (Pubitemid 43807558)
3. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A (2009) Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22:664-689
4. Warburg WG, Korem M, Robicsek A, Engelstein D, Moses AE, Block C et al (2009) Changes in aac(6')-Ib-cr prevalence and fluoroquinolone resistance in nosocomial isolates of Escherichia coli collected from 1991 through 2005. Antimicrob Agents Chemother 53:1268-1270
5. Galatti L, Sessa A, Mazzaglia G, Pecchioli S, Rossi A, Cricelli C et al (2006) Antibiotic prescribing for acute and recurrent cystitis in primary care: a 4 year descriptive study. J Antimicrob Chemother 57:551-556 (Pubitemid 43240209)
6. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L et al (2009) The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 34:407-413
7. Piatti G, Mannini A, Balistreri M, Schito AM (2008) Virulence factors in urinary Escherichia coli strains: Phylogenetic background and quinolone and fluoroquinolone resistance. J Clin Microbiol 46:480-487 (Pubitemid 351231290)
8. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement M100-S15. CLSI, Wayne, PA
9. Pallecchi L, Bartoloni A, Fiorelli C, Mantella A, Di Maggio T, Gamboa H, Gotuzzo E, Kronvall G, Paradisi F, Rossolini GM (2007) Rapid dissemination and diversity of CTX-M extendedspectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. Antimicrob Agents Chemother 51:2720-2725 (Pubitemid 47206205)
10. Park CH, Robicsek A, Jacoby GA, Sahm DF, Hooper DC (2006) Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50:3953-3955 (Pubitemid 44684926)
11. Carattoli A, García-Fernández A, Varesi P, Fortini D, Gerardi S, Penni A, Mancini C, Giordano A (2008) Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J Clin Microbiol 46:103-108
12. Gagliotti C, Mazzetti I, Moro ML (2009) Comparison of sales and reimbursement data regarding outpatient antibiotic use in a northern Italian region. Pharmacoepidemiol Drug Saf 18:1115- 1118
13. Metlay JP, Strom BL, Asch DA (2003) Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 51:963- 970 (Pubitemid 36503430)
14. Amin AK, Wareham DW (2009) Plasmid-mediated quinolone resistance genes in Enterobacteriaceae isolates associated with community and nosocomial urinary tract infection in East London, UK. Int J Antimicrob Agents 34:490-491